abc
QUICK LINKS:

FDA Approves Once-a-Day Inhaler Drug

Updated: 07/31/2014 5:36 PM
Created: 07/31/2014 5:35 PM WDIO.com

WASHINGTON (AP) - The Food and Drug Administration has approved a new long-acting inhaler drug from Boehringer Ingelheim to treat people with chronic lung disease.

The agency approved Striverdi Respimat for chronic obstructive pulmonary disease, which causes bronchitis and emphysema and affects about 24 million people in the U.S. The disease, which is most often caused by smoking, is the third leading cause of death in the U.S., according to the National Institutes of Health.

The FDA approved the drug on Thursday based on a study in 3,104 patients which showed improvements in lung function versus placebo.

The drug will carry a bold warning that it is not approved to treat patients with asthma. Striverdi Respimate is part of a family of medications that have been linked to asthma-related deaths.

(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Front Page

 

Winter Weather Advisory

MN AREAS AFFECTED: Central St. Louis; North Cass; North Itasca; North St. Louis; Northern Cook, Northern Lake; South Itasca; Southern Cook, North Shore
Expires: 3/4/2015 12:00 AM

Winter Weather Advisory

MN AREAS AFFECTED: Carlton, South St. Louis; Pine; Southern Lake, North Shore
Expires: 3/4/2015 12:00 AM

Winter Weather Advisory

MN AREAS AFFECTED: Crow Wing; Northern Aitkin; South Aitkin; South Cass
Expires: 3/4/2015 12:00 AM

Winter Weather Advisory

WI AREAS AFFECTED: Ashland; Bayfield; Burnett; Douglas; Iron; Price; Sawyer; Washburn
Expires: 3/4/2015 12:00 AM

Winter Weather Advisory

MI AREAS AFFECTED: Baraga; Houghton; Keweenaw; Marquette; Ontonagon; Southern Houghton
Expires: 3/3/2015 7:00 PM

Winter Weather Advisory

MI AREAS AFFECTED: Dickinson; Gogebic; Iron; Menominee
Expires: 3/3/2015 7:00 PM

Advertisement
Advertisement
Advertisement
Advertisement